SEPTERNA, INC. COMMON STOCK

NASDAQ: SEPN (Septerna, Inc.)

Last update: 3 days ago, 8:55AM

48.00

0.65 (1.37%)

Previous Close 47.35
Volume 5,593
Price / Sales 21.70
Price / Book 5.67
52 Weeks Range
17.55 (-63%) — 51.10 (6%)
Operating Margin (TTM) -11,831.05%
Diluted EPS (TTM) -1.78
Quarterly Revenue Growth (YOY) -30.90%
Total Debt/Equity (MRQ) 6.25%
Current Ratio (MRQ) 32.19
Operating Cash Flow (TTM) -74.10 M
Levered Free Cash Flow (TTM) -25.69 M
Return on Assets (TTM) -17.20%
Return on Equity (TTM) -30.96%

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Mixed Bullish
Biotechnology (Global) Mixed Bullish
Stock Septerna, Inc. Mixed Bullish

AIStockmoo Score

0.9
Value 35% 0.0
AI Insight info NA
Relative Valuation info NA
Financial Health info 0.0
Timing 35% 3.4
AI Technical info NA
Technical Oscillators info 4.0
Technical Moving Averages info 2.5
Smart Money 30% 0.0
Analyst Consensus info 0.0
Insider Activity info NA
Environment ×0.79
Macro Environment info -3.3
Sector vs Market (6M) -21.3%
Pillar Agreement ×1.00
Not in score
Price Volatility info -3.0
Final Score 0.94

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
SEPN - - - 5.67
ARDX - - - 4.40
PTGX - - - 10.38
CNTN - - - 0.370
PRAX - - - 5.48
RLMD - - - 2.02

Select this tab to load the latest available analysis.

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.

Sector Healthcare
Industry Biotechnology
Investment Style Small Growth
% Held by Insiders 2.64%
% Held by Institutions 105.46%

Ownership

Name Date Shares Held
Trv Gp V, Llc 30 Jun 2026 6,215,591
Trv Gp Vi, Llc 30 Jun 2026 4,211,659

No data within this time range.

No data within this time range.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2026 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria